TGF-β-signaling pathway: In ovarian cancer cells, the down-regulation of GPC3 expression by RNA interference has been shown to elevate the levels of TGF-β2 protein, accompanied by the increase in cell proliferation and tumor growth in vivo. This evidence concerns the gene GPC3 and ovarian carcinoma.